Catalyst Wire Dossier Catalyst Wire Dossier

MINOXIDIL TOPICAL SOLUTION, 5%

MINOXIDIL SOLUTION · Sun Pharmaceutical Industries, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MINOXIDIL TOPICAL SOLUTION, 5%, covering 2016-09-02 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Study of Microneedling With Topical Minoxidil 5% ± NB-UVB in Stable Vitiligo" [Phase 2]

See pricing